Glycogen phosphorylase BB as a marker of cardiac toxicity during hematopoietic cell transplantation in hematooncology

Abstract

We evaluated cardiac toxicity during hematopoietic cell transplantation (HCT) for hematological malignancies with multiple biomarkers of cardiac injury including glycogen phosphorylase BB (GPBB).